Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Goodwill & Intangibles: 2013-2024

Historic Goodwill & Intangibles for ImmunityBio (IBRX) over the last 11 years, with Dec 2024 value amounting to $15.9 million.

  • ImmunityBio's Goodwill & Intangibles fell 12.16% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year decrease of 12.16%. This contributed to the annual value of $15.9 million for FY2024, which is 6.79% down from last year.
  • As of FY2024, ImmunityBio's Goodwill & Intangibles stood at $15.9 million, which was down 6.79% from $17.1 million recorded in FY2023.
  • ImmunityBio's 5-year Goodwill & Intangibles high stood at $20.0 million for FY2022, and its period low was $1.4 million during FY2021.
  • In the last 3 years, ImmunityBio's Goodwill & Intangibles had a median value of $17.1 million in 2023 and averaged $17.7 million.
  • Per our database at Business Quant, ImmunityBio's Goodwill & Intangibles skyrocketed by 1,308.66% in 2022 and then declined by 14.55% in 2023.
  • ImmunityBio's Goodwill & Intangibles (Yearly) stood at $1.5 million in 2020, then dropped by 2.94% to $1.4 million in 2021, then skyrocketed by 1,308.66% to $20.0 million in 2022, then decreased by 14.55% to $17.1 million in 2023, then dropped by 6.79% to $15.9 million in 2024.